Design and optimization of sunitinib-loaded γ-cyclodextrin metal-organic frameworks: Effects of particle size modulators on physicochemical properties, solubility, and cytotoxicity
Journal of Drug Delivery Science and Technology, cilt.127, 2027 (SCI-Expanded, Scopus)
- Yayın Türü: Makale / Tam Makale
- Cilt numarası: 127
- Basım Tarihi: 2027
- Doi Numarası: 10.1016/j.jddst.2026.109060
- Dergi Adı: Journal of Drug Delivery Science and Technology
- Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, EMBASE
- Anahtar Kelimeler: Drug delivery, Particle size modulators, Solubility enhancement, Sunitinib, ɣ-cyclodextrin metal-organic framework
- Gazi Üniversitesi Adresli: Evet
Özet
Poor aqueous solubility and limited permeability remain major challenges in the oral delivery of many small-molecule drugs, particularly those classified as Biopharmaceutics Classification System (BCS) Class IV compounds. While γ-cyclodextrin-based metal–organic frameworks (γ-CD-MOFs) have attracted increasing attention as drug delivery platforms, a comparative evaluation of γ-CD-MOF synthesis and drug-loading parameters governing particle characteristics, loading performance, and carrier cytocompatibility remains limited. In this study, γ-CD-MOFs were comparatively evaluated using three different particle size modulators— polyethylene glycol 20000 (PEG20000), cetyltrimethylammonium bromide (CTAB), and triethanolamine (TEA)—followed by sequential optimization of selected formulation and drug-loading parameters. SUN was encapsulated into γ-CD-MOFs via co-crystallization and impregnation methods, while impregnation yielded a higher loading efficiency of up to 40% at a γ-CD:SUN molar ratio of 1:3. Physicochemical and structural characterization confirmed the successful incorporation of SUN within the γ-CD-MOF framework and revealed the partial amorphization of the drug after encapsulation. Among the investigated formulations, γ-CD-MOF–PEG20000 exhibited the most favorable properties, including reduced particle size (∼400 nm), low polydispersity index (∼0.2), appropriate zeta potential, high loading efficiency (∼%40), and no cytotoxicity toward L929 fibroblast cells, whereas γ-CD-MOF–CTAB reduced cell viability below 80%. Solubility studies conducted in gastrointestinal-simulating buffer media demonstrated a pronounced enhancement in SUN solubility for all γ-CD-MOF formulations, especially at pH 6.8. This improvement was attributed to the porous structure and high surface area of γ-CD-MOFs, reduced particle size and partial amorphization of SUN within the MOF cavities. Overall, this study demonstrates how particle-size modulator type and selected formulation parameters influence the physicochemical properties, drug-loading performance, solubility enhancement and carrier cytocompatibility of SUN-loaded γ-CD-MOFs on L-929 cell line. Further dissolution, permeability and in vivo studies are required to determine whether these physicochemical advantages translate into improved oral drug delivery performance.